Export 26 results:
Author [ Title(Desc)] Type Year
Filters: Author is Scott, Ingrid U  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
I. U. Scott, VanVeldhuisen, P. C., Oden, N. L., Ip, M. S., Blodi, B. A., J Jumper, M., and Figueroa, M., SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion., Ophthalmology, vol. 116, no. 3, pp. 504-12, 2009.
C. K. Chan, Ip, M. S., VanVeldhuisen, P. C., Oden, N. L., Scott, I. U., Tolentino, M. J., and Blodi, B. A., SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion., Ophthalmology, vol. 118, no. 7, pp. 1364-72, 2011.
D. V. Weinberg, Wahle, A. E., Ip, M. S., Scott, I. U., VanVeldhuisen, P. C., and Blodi, B. A., Score Study Report 12: Development of venous collaterals in the Score Study., Retina, vol. 33, no. 2, pp. 287-95, 2013.
I. U. Scott, Blodi, B. A., Ip, M. S., VanVeldhuisen, P. C., Oden, N. L., Chan, C. K., and Gonzalez, V., SCORE Study Report 2: Interobserver agreement between investigator and reading center classification of retinal vein occlusion type., Ophthalmology, vol. 116, no. 4, pp. 756-61, 2009.
M. S. Ip, Oden, N. L., Scott, I. U., VanVeldhuisen, P. C., Blodi, B. A., Figueroa, M., Antoszyk, A., and Elman, M., SCORE Study report 3: study design and baseline characteristics., Ophthalmology, vol. 116, no. 9, pp. 1770-1777.e1, 2009.
I. U. Scott, Oden, N. L., VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., and Antoszyk, A. N., SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design., Am J Ophthalmol, vol. 148, no. 5, pp. 725-732.e7, 2009.
N. Oden, VanVeldhuisen, P. C., Scott, I. U., and Ip, M. S., SCORE Study Report 8: Closed Tests for All Pair-Wise Comparisons of Means., Drug Inf J, vol. 44, no. 4, pp. 405-420, 2010.
A. Hendrick, VanVeldhuisen, P. C., Scott, I. U., King, J., Blodi, B. A., Ip, M. S., Khurana, R. N., and Oden, N. L., SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes With Central or Hemiretinal Vein Occlusion Managed With Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical Trials., Am J Ophthalmol, vol. 222, pp. 185-193, 2020.
I. U. Scott, Figueroa, M. J., Oden, N. L., Ip, M. S., Blodi, B. A., and VanVeldhuisen, P. C., SCORE2 Report 5: Vision-Related Function in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion., Am J Ophthalmol, vol. 184, pp. 147-156, 2017.
T. Etheridge, Blodi, B., Oden, N., Van Veldhuisen, P., Scott, I. U., Ip, M. S., Mititelu, M., and Domalpally, A., Spectral Domain Optical Coherence Tomography Predictors of Visual Acuity in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2)., Ophthalmol Retina, 2020.
B. A. Blodi, Domalpally, A., Scott, I. U., Ip, M. S., Oden, N. L., Elledge, J., Warren, K., Altaweel, M. M., Kim, J. E., and Van Veldhuisen, P. C., Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study system for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE Study Report 9., Arch Ophthalmol, vol. 128, no. 9, pp. 1140-5, 2010.